Groupe IRD

Groupe IRD ROE

Delisted

The Return on Equity (ROE) of Groupe IRD (IRD.PA) as of Nov 8, 2026 is 12.48 %. In the previous year, Return on Equity (ROE) was 5.74 % — a change of 117.50% (higher).

ROE

12.48 %

YoY

117.50%

Last updated:

In 2021, Groupe IRD's return on equity (ROE) was 12.48 %, a 117.50% increase from the 5.74 % ROE in the previous year.

The Groupe IRD ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2015
3.62 EUR
Jan 1, 2016
4.99 EUR
Jan 1, 2017
3.67 EUR
Jan 1, 2018
8.47 EUR
Jan 1, 2019
6.15 EUR
Jan 1, 2020
5.74 EUR
Jan 1, 2021
12.48 EUR
The Groupe IRD ROE history
YEARROEYoY
12.48 %+117.50%
5.74 %-6.74%
6.15 %-27.34%
8.47 %+130.79%
3.67 %-26.49%
4.99 %+37.76%
3.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Groupe IRD Stock analysis

What does Groupe IRD do? Groupe IRD SA is an internationally active company specializing in the development and production of medical diagnostics and food tests. The company's history dates back over 70 years, when it was founded by Dr. Paul Dettwiler in 1949. Since then, the company has grown from a small laboratory to a world-leading provider of tests for medicine and food safety. Groupe IRD SA's business model is based on innovative technologies, product quality, and customer orientation. The company has various business divisions that focus on the different needs of its customers. The diagnostic division is involved in the manufacture and distribution of medical tests for laboratory diagnostics, particularly for infectious diseases such as HIV, hepatitis, or tuberculosis. IRD offers a comprehensive range of tests, ranging from simple rapid tests to advanced diagnostic platforms. Another important area of Groupe IRD SA is food safety. The company develops and produces fast, reliable, and precise tests to examine a variety of foods for potential contaminants such as pesticides, antibiotics, or allergens. These tests are used in both food production facilities and by authorities. IRD is also a major manufacturer of test kits for animal health. These include tests for the early detection of infectious diseases such as brucellosis or paratuberculosis. Veterinarians and farmers use these tests to protect their herds from disease outbreaks. In addition to the three core areas, IRD also operates an extensive service program that provides assistance to its customers in setting up laboratories and conducting training in test handling. The company strives to work closely with its customers to understand their needs and offer them the best possible products and services. Innovation and research play a major role in the corporate philosophy of Groupe IRD SA. The company continuously invests in the development of new products and technologies and is always seeking to improve its existing products. IRD also places great importance on sustainable and environmentally friendly production, and strives to minimize its ecological footprint. Overall, Groupe IRD SA has become an internationally active company with nearly 200 employees and operates in over 100 countries worldwide. The company has earned an excellent reputation as a reliable manufacturer of diagnostic and food test kits and is constantly striving to improve its products and satisfy its customers. Groupe IRD is one of the most popular companies on Eulerpool.

ROE Details

Decoding Groupe IRD's Return on Equity (ROE)

Groupe IRD's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Groupe IRD's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Groupe IRD's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Groupe IRD’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Groupe IRD stock

Return on Equity (ROE) of Groupe IRD is 12.48 % in 2021.

Return on Equity (ROE) of Groupe IRD changed from 5.74 % to 12.48 %, representing a 117.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Groupe IRD since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Groupe IRD with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Groupe IRD

All Key Metrics — Groupe IRD